D007610Chemicals & DrugsD08.811.277.656.300.760.442D08.811.277.656.959.350.442D12.776.124.125.597D23.119.59734470.973987Kallikreinsprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1.247390.0072285234research area of0.7697440.0074215841subject area for29261442Harshman LC, Chen YH, Liu G, Carducci MA, Jarrard D, Dreicer R, Hahn N, Garcia JA, Hussain M, Shevrin D, Eisenberger M, Kohli M, Plimack ER, Cooney M, Vogelzang NJ, Picus J, Dipaola R, Sweeney CJ, ECOG-ACRIN 3805 InvestigatorsJournal of clinical oncology : official journal of the American Society of Clinical OncologySeven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel. J Clin Oncol. 2018 02 01; 36(4):376-382.J Clin Oncol2017-12-20T00:00:002017Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel.32432506Eggener SThe Journal of urologyEditorial Comment. J Urol. 2020 08; 204(2):287.J Urol2020-05-20T00:00:002020Editorial Comment.32552276Xie W, Regan MM, Buyse M, Halabi S, Kantoff PW, Sartor O, Soule H, Berry D, Clarke N, Collette L, D'Amico A, Lourenco RA, Dignam J, Eisenberger M, James N, Fizazi K, Gillessen S, Loriot Y, Mottet N, Parulekar W, Sandler H, Spratt DE, Sydes MR, Tombal B, Williams S, Sweeney CJ, ICECaP Working GroupJournal of clinical oncology : official journal of the American Society of Clinical OncologyEvent-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation. J Clin Oncol. 2020 09 10; 38(26):3032-3041.J Clin Oncol2020-06-18T00:00:002020Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation.TedSkolarusTed Skolarus41.7886000000000087.598699999999994249Skolarus, TedProfessor27458297Mittakanti HR, Thomas IC, Shelton JB, Makarov DV, Skolarus TA, Cooperberg MR, Chung BI, Sonn GA, Brooks JD, Leppert JTJournal of clinical oncology : official journal of the American Society of Clinical OncologyAccuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries. J Clin Oncol. 2016 10 10; 34(29):3586-3587.J Clin Oncol2016-10-10T00:00:002016Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries.Human GeneticsPathologyUniversity of ChicagoScott E.EggenerScott E. Eggener41.78927490000000-87.601250000000001156Eggener, Scott E.ProfessorGladell P.PanerGladell P. Paner41.78927490000000-87.60125000000000146Paner, Gladell P.ProfessorCancer BiologySimonHaywardSimon Hayward41.7886000000000087.598699999999994469Hayward, SimonJean Ruggles Romoser Chair of Cancer Research30370673Sasaki T, Franco OE, Ohishi K, Filipovich Y, Ishii K, Crawford SE, Takahashi N, Katayama N, Sugimura Y, Hayward SWThe ProstateTyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients. Prostate. 2019 02; 79(3):259-264.Prostate2018-10-28T00:00:002018Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients.RachelMyersRachel Myers41.78927490000000-87.6012500000000061Myers, RachelPostdoctoral Scholartrue1Jean Ruggles Romoser Chair of Cancer ResearchJean Ruggles Romoser Chair of Cancer Researchtrue1Postdoctoral ScholarPostdoctoral Scholartrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorSurgery-Urology